Active ingredient
- bimatoprost
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet are: EU/1/02/205/004, EU/1/02/205/003.
Lumigan 0.1mg/ml
Package leaflet: Information for the user
LUMIGAN 0.1 mg/ml, eye drops, solution
Bimatoprost
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
What is in this leaflet:
1. What LUMIGAN 0.1 mg/ml is and what it is used for
2. What you need to know before you use LUMIGAN 0.1 mg/ml
3. How to use LUMIGAN 0.1 mg/ml
4. Possible side effects
5. How to store LUMIGAN 0.1 mg/ml
6. Contents of the pack and other information
1. What LUMIGAN 0.1 mg/ml is and what it is used for
LUMIGAN is an antiglaucoma preparation. It belongs to a group of medicines called prostamides.
LUMIGAN eye drops are used to reduce high pressure in the eye. This medicine may be used on its own or with other drops called beta-blockers which also reduce pressure.
Your eye contains a clear, watery liquid that feeds the inside of the eye. Liquid is constantly being drained out of the eye and new liquid is made to replace this. If the liquid cannot drain out quickly enough, the pressure inside the eye builds up. This medicine works by increasing the amount of liquid that is drained. This reduces the pressure inside the eye. If the high pressure is not reduced, it could lead to a disease called glaucoma and eventually damage your sight.
2. What you need to know before you use LUMIGAN 0.1 mg/ml
Do not use LUMIGAN 0.1 mg/ml:
Warnings and precautions:
Talk to your doctor or pharmacist before you use LUMIGAN 0.1 mg/ml
Talk to your doctor, if:
LUMIGAN may cause your eyelashes to darken and grow, and cause the skin around the eyelid to darken too. The colour of your iris may also go darker over time. These changes may be permanent. The change may be more noticeable if you are only treating one eye.
Children and adolescents
LUMIGAN has not been tested in children under the age of 18 and therefore should not be used by patients under 18 years.
Other medicines and LUMIGAN
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregnancy and breast-feeding
If you are pregnant or breast feeding, think you might be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.
LUMIGAN may get into breast milk so you should not breast-feed while you are taking LUMIGAN.
Driving and using machines
Your sight may become blurred for a short time just after using LUMIGAN. You should not drive or use machines until your sight is clear again.
LUMIGAN 0.1 mg/ml contains benzalkonium chloride
This medicine contains 0.6 mg benzalkonium chloride in each 3 ml of solution which is equivalent to 0.2 mg/ml.
Do not use the drops when you are wearing your lenses. A preservative in LUMIGAN, benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and wait 15 minutes after using the drops before you put your lenses back in. Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
3. How to use LUMIGAN 0.1 mg/ml
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
LUMIGAN should only be applied to the eye. The recommended dose is one drop of LUMIGAN in the evening, once daily in each eye that needs treatment.
If you use LUMIGAN with another eye medicine, wait at least five minutes between using LUMIGAN and the other eye medicine.
Do not use more than once a day as the effectiveness of treatment may be reduced.
Instructions for use:
You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first use it.
1. Wash your hands. Tilt your head back and look at the ceiling.
2. Gently pull down the lower eyelid until there is a small pocket.
3. Turn the bottle upside down and squeeze it to release one drop into each eye that needs treatment.
4. Let go of the lower lid, and close your eye for 30 seconds.
Wipe off any excess that runs down the cheek.
If a drop misses your eye, try again.
To help prevent infections and avoid eye injury, do not let the tip of the bottle touch your eye or anything else. Put the cap back on and close the bottle straight after you have used it.
If you use more LUMIGAN 0.1 mg/ml than you should
If you use more LUMIGAN than you should, it is unlikely to cause you any serious harm. Put your next dose in at the usual time. If you are worried, talk to your doctor or pharmacist.
If you forget to use LUMIGAN 0.1 mg/ml
If you forget to use LUMIGAN, use a single drop as soon as you remember, and then go back to your regular routine. Do not take a double dose to make up for a forgotten dose.
If you stop using LUMIGAN 0.1 mg/ml
LUMIGAN should be used every day to work properly. If you stop using LUMIGAN the pressure inside your eye may go up, therefore talk to your doctor before stopping this treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects
These may affect one or more users in 10
Affecting the eye
Common side effects
These may affect 1 to 9 users in 100
Affecting the eye
Affecting the skin
Uncommon side effects
These may affect 1 to 9 users in 1000
Affecting the eye
Affecting the skin
Affecting the body
Side effects where the frequency is not known
Affecting the eye
Affecting the body
In addition to the side effects for LUMIGAN 0.1 mg/ml, the following side effects have been seen with another medicine containing a higher strength of bimatoprost (0.3 mg/ml):
Other side effects reported with eye drops containing phosphates
In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment.
Reporting side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:
UK
Ireland
Malta
By reporting side effects you can help provide more information on the safety of the medicine.
5. How to store LUMIGAN 0.1 mg/ml
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle label and the carton after EXP. The expiry date refers to the last day of that month.
You must throw away the bottle at the latest four weeks after you first opened it, even if there are still some drops left. This will prevent infections. To help you remember, write down the date you opened it in the space on the box.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. Contents of the pack and other information
What LUMIGAN 0.1 mg/ml contains
What LUMIGAN 0.1 mg/ml looks like and contents of the pack
LUMIGAN is a colourless clear eye drop solution in a pack containing either 1 plastic bottle or 3 plastic bottles each with a screw cap. Each bottle is approximately half full and contains 3 millilitres of solution. This is enough for 4 weeks’ usage. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
For any information about this medicine, please contact the local representative of the marketing authorisation holder.
This leaflet was last revised in 05/2020
Detailed information on this medicinal product is available on the European Medicines Agency web site: http://www.ema.europa.eu.
Version 12
Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
+44 (0)1628 494444
+44 (0)1628 494026
+44 (0)1628 494026